Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
11.76
-1.49 (-11.25%)
May 18, 2026, 4:00 PM EDT - Market closed
Eikon Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$25.20
Upside
+114.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Sell Maintains $7 → $5 | Sell | Maintains | $7 → $5 | -57.48% | May 12, 2026 |
| Wedbush | Wedbush | Sell Reiterates $7 | Sell | Reiterates | $7 | -40.48% | Mar 31, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 2, 2026 |
| JP Morgan | JP Morgan | Buy Initiates $29 | Buy | Initiates | $29 | +146.60% | Mar 2, 2026 |
| B of A Securities | B of A Securities | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +189.12% | Mar 2, 2026 |
| Mizuho | Mizuho | Buy Initiates $26 | Buy | Initiates | $26 | +121.09% | Mar 2, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $32 | Buy | Initiates | $32 | +172.11% | Mar 2, 2026 |
| Wedbush | Wedbush | Sell Initiates $7 | Sell | Initiates | $7 | -40.48% | Feb 26, 2026 |